Cetylpyridinium chloride
Sponsors
Sanofi, Seoul National University Hospital, Johns Hopkins Bloomberg School of Public Health, University of Illinois at Chicago
Conditions
HealthyHygieneOral MicrobiomePeriodontitisPremature Birth of NewbornSarcopeniaWound Heal
Early Phase 1
Phase 2
Phase 3
Safety Oral Mucosa Evaluation - Acceptability With Odontological Follow up - Cepacol Canela Power
CompletedNCT00687037
Start: 2008-01-31Updated: 2009-02-13
Safety Dermatological Evaluation: Acceptability With Odontological Follow up - Cepacol Teen.
CompletedNCT00729599
Start: 2008-07-31Updated: 2009-03-04